The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Friday, 24 May 2019
The theme of the recent British Society for HF (BSH) annual conference was ‘The heart failure Multidisciplinary Team’. This was timely given the publication of three key reports within the last few months, all presented at the meeting, which referenced the importance of multidisciplinary care. The conference had a sell-out audience of >900 delegates and speakers including cardiologists, nurses, pharmacists, geriatricians, GPs, respiratory physicians, psychologists, third sector organisations and patients.
Category: Editorial
Topics covered:
Friday, 17 May 2019
The NICE 2015 guidelines on the diagnosis and management of menopause provides useful evidence-based guidance on the menopause, but it is unclear if many GPs are able to confidently prescribe appropriate hormone replacement therapy (HRT).  This brief article gives an overview of the importance of HRT and aims to help GPs to manage their patients experiencing menopause.
Category: Editorial
Topics covered:
Thursday, 18 April 2019
As many as 16 million people in the UK are estimated to have hypertension, and around 7 million of these are undiagnosed. Of those diagnosed in England, one third are not receiving optimum management.
Category: Editorial
Topics covered:
Thursday, 18 April 2019
Obesity is estimated to be responsible for more than 30,000 deaths each year, reducing lifespan by an average of nine years. The links between obesity, diabetes and cardiovascular disease are well documented, but overweight and obesity also causes 6% of cancers in the UK. These figures have resulted in warnings that obesity is the new smoking when it comes to risks to health and longevity. So the problem is clear. The challenge is to put into action what works.
Category: Editorial
Topics covered:
Thursday, 18 April 2019
Cardiovascular disease (CVD) is the leading cause of death worldwide. Elevated blood pressure (BP) is the main global risk factor for premature morbidity and mortality, and the prevalence of hypertensive heart disease is not declining over time. Improved control of high BP is, therefore, fundamental to further prevention of CVD, and adoption of treatment guidelines can have a positive impact on BP-related outcomes.
Category: Editorial
Wednesday, 10 April 2019
A large study in the USA has found that starting treatment for sleep apnoea as soon as possible after a stroke or a transient ischaemic attack (TIA) significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning. Continuous Positive Airway Pressure (CPAP) therapy was shown to provide even greater benefits than tPA (tissue plasminogen activator) which is a NICE recommended drug treatment for stroke.
Topics covered:
Monday, 08 April 2019
Our regular Evidence in Practice feature summarizes recent scientific papers focusing on different aspects of cardiovascular medicine. This month we feature recent research showing that anti-inflammatory biological drugs used to treat severe psoriasis have the potential to prevent heart in patients with the condition. Over one year of treatment, biological therapy improved coronary artery plaques in a manner similar to a low-dose statin.
Tuesday, 02 April 2019
A local GP practice in Milton Keynes has designed a valuable tool to triage patients presenting with chest pain and to help them avoid unnecessary emergency hospital admissions.  The locality has no dedicated unit, so patients require either emergency hospital admission, a referral to Rapid Access Chest Pain Clinic (RACP), cardiology outpatient clinic (OPD), or management in primary care.
Category: Editorial
Monday, 01 April 2019
The Public Health England (PHE) action plan for 2017-181 outlined the scale of the cardiovascular disease (CVD) issue we face here in the UK. Affecting around 7 million people, CVD remains a significant cause of disability and death. In England, we know that it is responsible for one in four premature deaths and over a quarter of all deaths, which not only affect the individual but also their families, and impact the wider community too. Healthcare costs associated with CVD are estimated at £8.96 billion and non-healthcare costs at about £4.04 billion. 2 A recent report discusses the evidence for the success of population-based CVD prevention programmes in reducing the burden of illness for individuals and society.
Monday, 01 April 2019
The NHS Health Check is a national programme offering a health check-up every five years to adults in England aged 40 to 74 without a pre-existing cardiovascular condition. One of the largest prevention programmes of its type in the world, the programme is designed to help prevent and detect early signs of heart disease, stroke, kidney disease, type 2 diabetes and dementia. 1 This article reviews the evidence that has accumulated since the programme was established.

Article search and filter